Infectious disease
Do heart and metabolic conditions cause worse COVID-19?
Open access · cc by · source: Europe PMC
Of 17 heart and metabolic risk factors tested with genetic methods, only higher BMI showed evidence of causally raising the risk of being hospitalized with COVID-19.
Study at a glance
- Design
- Mendelian randomisation — Two-sample MR using published GWAS summary statistics for 17 cardiometabolic exposures and COVID-19 Host Genetics Initiative outcome GWAS (round 4), with pleiotropy-robust sensitivity analyses and multivariable MR
- N
- Summary-level data; primary susceptibility outcome 14,134 cases vs 1,284,876 population controls, primary severity outcome 6,406 hospitalized cases vs 902,088 controls, all of European ancestry
- Population
- Participants of mostly European ancestry in 22 cohorts contributing to the COVID-19 Host Genetics Initiative, plus large exposure GWAS consortia
- Outcome
- COVID-19 susceptibility (testing positive) and severity (hospitalization), plus five secondary COVID-19 outcome definitions
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Only BMI passed the strict multiple-testing threshold for severity: each 1 kg/m² genetically higher BMI was linked to 14% higher odds of COVID-19 hospitalization (odds ratio 1.14) and 6% higher odds of testing positive, though the latter did not meet the corrected threshold. None of the other exposures, including type 2 diabetes and blood pressure, showed significant associations. When coronary disease, stroke, kidney disease or type 2 diabetes were each added alongside BMI in multivariable models, BMI's direct effect disappeared, hinting that its effect may run through these conditions.
Methodology
The researchers used Mendelian randomization, which treats genetic variants that shift a risk factor as a natural experiment, to test 17 cardiometabolic exposures such as type 2 diabetes, BMI, blood pressure, lipids, coronary disease and kidney disease. Genetic effects on each exposure came from large published genome-wide studies, and genetic effects on COVID-19 came from the COVID-19 Host Genetics Initiative. The two primary outcomes were testing positive (14,134 cases) and being hospitalized (6,406 cases), each compared with population controls. They then ran sensitivity methods robust to pleiotropy and multivariable analyses to see whether BMI acted through obesity-related diseases.
Limitations
Genetic instruments explained only a small share of variance in each exposure, so modest causal effects of the other risk factors cannot be ruled out; null results are not proof of no effect. Pleiotropy-robust methods such as MR-Egger were weaker, so the BMI result could still be partly biased by pleiotropy. Participants were mostly European and non-randomly selected into biobanks, which risks collider/selection bias, and 'controls' were anyone not recorded as a case, so undetected infections could dilute effects. The analysis assumed linear effects and could not check differences by sex.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- Does bacterial vaginosis make HIV easier to pass to men?
- How much could closing schools slow a close-contact epidemic?
- Does an earlier dengue infection protect children from Zika?
- Is a disrupted gut linked to how sick COVID-19 patients get?
- How do teens born with HIV fare in different parts of the world?